Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06535152 · ClinicalTrials.gov registry record · NA
Lifelight Non-Invasive Blood Pressure and Heart Rate Validation Study
A NA study of Hypertension, sponsored by Xim Limited.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 1
- Study location
NCT06535152: Completed NA study of Hypertension, sponsored by Xim Limited.
NCT06535152 is a NA study of Hypertension that has completed, run by Xim Limited. The registered enrollment target is 85 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06535152, a NA study of Hypertension, has completed, sponsored by Xim Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
Lifelight is a novel, calibration-free, software-only medical device that contactlessly measures pulse rate and blood pressure by measuring remote photoplethysmography (rPPG) signals of a patient's face using a standard smartphone or tablet camera. By conducting this validation study we aimed to demonstrate the accuracy of Lifelight for classifying the full range of clinically relevant blood pressures as hypertensive or non-hypertensive and demonstrate its accuracy for measuring pulse rate and the blood pressure of people with blood pressures relevant to Stage 1 hypertension.
Primary Outcome
Demonstrate the accuracy of Lifelight for classifying the full range of clinically relevant blood pressures as hypertensive or non-hypertensive.
Conditions Studied
Interventions
- DEVICE Lifelight
- DEVICE Manual sphygmomanometer
Study Locations (1)
Colorado
- Element Materials Technology - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2023-05-18 |
| Est. Completion | 2023-08-03 |
| Phase | NA |
What the finished NCT06535152 record still lists
NCT06535152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Lifelight is the first listed.
NCT06535152 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06535152 about?
NCT06535152 is a clinical study titled "Lifelight Non-Invasive Blood Pressure and Heart Rate Validation Study". Lifelight is a novel, calibration-free, software-only medical device that contactlessly measures pulse rate and blood pressure by measuring remote photoplethysmography (rPPG) signals of a patient's face using a standard smartphone or tablet camera. By conducting this validation study we aimed to de...
What is the current status of trial NCT06535152?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2023-05-18. Estimated completion is 2023-08-03.
What conditions does trial NCT06535152 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT06535152?
The interventions under investigation include: Lifelight (DEVICE), Manual sphygmomanometer (DEVICE).
Who is sponsoring clinical trial NCT06535152?
This trial is sponsored by Xim Limited, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06535152 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06535152's enrollment target sits among peer trials
85 313th of 470 higher than 156 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI